No difference in implant survival between 28-mm M2a RingLoc metal-on-metal and metal-on-polyethylene total hip arthroplasty: results from the Finnish Arthroplasty Register
Background and purpose: Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur, Switzerland). Biomet MoM THA was frequently used in Finland. Therefore, we assessed long-term survivorship of the M2a...
Gespeichert in:
| Veröffentlicht in: | Acta orthopaedica Jg. 93; S. 854 - 858 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Sweden
Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation
24.11.2022
Medical Journals Sweden |
| Schlagworte: | |
| ISSN: | 1745-3674, 1745-3682, 1745-3682 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background and purpose: Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur, Switzerland). Biomet MoM THA was frequently used in Finland. Therefore, we assessed long-term survivorship of the M2a 28-mm RingLoc MoM THA (Biomet, Warsaw, IN, USA) and compared it with the metal-on-polyethylene (MoP) RingLoc THA from the same manufacturer.Patients and methods: We conducted a register study based on THAs from the Finnish Arthroplasty Register performed between January 1, 2000 and December 31, 2007. 290 28-mm head M2a MoM THAs and 1,647 28-mm head MoP THAs (reference group) were included. The endpoint was revision for any reason, or revision for aseptic loosening, osteolysis, liner wear, or metallosis as one group. Kaplan–Meier survival estimates were calculated, and revision risks were assessed using a Cox multiple regression model, both with 95% confidence intervals (CI).Results: No difference was found in the 15-year Kaplan–Meier survivorship between the 28-mm head M2a RingLoc MoM THA and the reference group for any reason for revision (87.7% [82.9–92.1] and 83.3% [81.0–85.3], respectively). The adjusted hazard ratio (HR) for any reason for revision for the MoM THA group compared with the reference group was at least equal or better (0.70 [0.48–1.02]). Both groups presented similar survival for revision for aseptic loosening of the cup, osteolysis, liner wear, or metallosis, at 96.2% (92.7–98.0) and 95.4% (93.9–96.5), respectively.Interpretation: In the long-term survival there was no difference between the M2a 28-mm RingLoc MoM THA and 28-mm MoP THA. Further follow-up regimens for M2a 28-mm RingLoc THA patients may be unnecessary, but long-term metal ion and radiological data is needed before any formal suggestions. |
|---|---|
| AbstractList | Background and purpose: Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur, Switzerland). Biomet MoM THA was frequently used in Finland. Therefore, we assessed long-term survivorship of the M2a 28-mm RingLoc MoM THA (Biomet, Warsaw, IN, USA) and compared it with the metal-on-polyethylene (MoP) RingLoc THA from the same manufacturer.Patients and methods: We conducted a register study based on THAs from the Finnish Arthroplasty Register performed between January 1, 2000 and December 31, 2007. 290 28-mm head M2a MoM THAs and 1,647 28-mm head MoP THAs (reference group) were included. The endpoint was revision for any reason, or revision for aseptic loosening, osteolysis, liner wear, or metallosis as one group. Kaplan–Meier survival estimates were calculated, and revision risks were assessed using a Cox multiple regression model, both with 95% confidence intervals (CI).Results: No difference was found in the 15-year Kaplan–Meier survivorship between the 28-mm head M2a RingLoc MoM THA and the reference group for any reason for revision (87.7% [82.9–92.1] and 83.3% [81.0–85.3], respectively). The adjusted hazard ratio (HR) for any reason for revision for the MoM THA group compared with the reference group was at least equal or better (0.70 [0.48–1.02]). Both groups presented similar survival for revision for aseptic loosening of the cup, osteolysis, liner wear, or metallosis, at 96.2% (92.7–98.0) and 95.4% (93.9–96.5), respectively.Interpretation: In the long-term survival there was no difference between the M2a 28-mm RingLoc MoM THA and 28-mm MoP THA. Further follow-up regimens for M2a 28-mm RingLoc THA patients may be unnecessary, but long-term metal ion and radiological data is needed before any formal suggestions. Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur, Switzerland). Biomet MoM THA was frequently used in Finland. Therefore, we assessed long-term survivorship of the M2a 28-mm RingLoc MoM THA (Biomet, Warsaw, IN, USA) and compared it with the metal-on-polyethylene (MoP) RingLoc THA from the same manufacturer.BACKGROUND AND PURPOSELong-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur, Switzerland). Biomet MoM THA was frequently used in Finland. Therefore, we assessed long-term survivorship of the M2a 28-mm RingLoc MoM THA (Biomet, Warsaw, IN, USA) and compared it with the metal-on-polyethylene (MoP) RingLoc THA from the same manufacturer.We conducted a register study based on THAs from the Finnish Arthroplasty Register performed between January 1, 2000 and December 31, 2007. 290 28-mm head M2a MoM THAs and 1,647 28-mm head MoP THAs (reference group) were included. The endpoint was revision for any reason, or revision for aseptic loosening, osteolysis, liner wear, or metallosis as one group. Kaplan-Meier survival estimates were calculated, and revision risks were assessed using a Cox multiple regression model, both with 95% confidence intervals (CI).PATIENTS AND METHODSWe conducted a register study based on THAs from the Finnish Arthroplasty Register performed between January 1, 2000 and December 31, 2007. 290 28-mm head M2a MoM THAs and 1,647 28-mm head MoP THAs (reference group) were included. The endpoint was revision for any reason, or revision for aseptic loosening, osteolysis, liner wear, or metallosis as one group. Kaplan-Meier survival estimates were calculated, and revision risks were assessed using a Cox multiple regression model, both with 95% confidence intervals (CI).No difference was found in the 15-year Kaplan-Meier survivorship between the 28-mm head M2a RingLoc MoM THA and the reference group for any reason for revision (87.7% [82.9-92.1] and 83.3% [81.0-85.3], respectively). The adjusted hazard ratio (HR) for any reason for revision for the MoM THA group compared with the reference group was at least equal or better (0.70 [0.48-1.02]). Both groups presented similar survival for revision for aseptic loosening of the cup, osteolysis, liner wear, or metallosis, at 96.2% (92.7-98.0) and 95.4% (93.9-96.5), respectively.RESULTSNo difference was found in the 15-year Kaplan-Meier survivorship between the 28-mm head M2a RingLoc MoM THA and the reference group for any reason for revision (87.7% [82.9-92.1] and 83.3% [81.0-85.3], respectively). The adjusted hazard ratio (HR) for any reason for revision for the MoM THA group compared with the reference group was at least equal or better (0.70 [0.48-1.02]). Both groups presented similar survival for revision for aseptic loosening of the cup, osteolysis, liner wear, or metallosis, at 96.2% (92.7-98.0) and 95.4% (93.9-96.5), respectively.In the long-term survival there was no difference between the M2a 28-mm RingLoc MoM THA and 28-mm MoP THA. Further follow-up regimens for M2a 28-mm RingLoc THA patients may be unnecessary, but long-term metal ion and radiological data is needed before any formal suggestions.INTERPRETATIONIn the long-term survival there was no difference between the M2a 28-mm RingLoc MoM THA and 28-mm MoP THA. Further follow-up regimens for M2a 28-mm RingLoc THA patients may be unnecessary, but long-term metal ion and radiological data is needed before any formal suggestions. Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur, Switzerland). Biomet MoM THA was frequently used in Finland. Therefore, we assessed long-term survivorship of the M2a 28-mm RingLoc MoM THA (Biomet, Warsaw, IN, USA) and compared it with the metal-on-polyethylene (MoP) RingLoc THA from the same manufacturer. We conducted a register study based on THAs from the Finnish Arthroplasty Register performed between January 1, 2000 and December 31, 2007. 290 28-mm head M2a MoM THAs and 1,647 28-mm head MoP THAs (reference group) were included. The endpoint was revision for any reason, or revision for aseptic loosening, osteolysis, liner wear, or metallosis as one group. Kaplan-Meier survival estimates were calculated, and revision risks were assessed using a Cox multiple regression model, both with 95% confidence intervals (CI). No difference was found in the 15-year Kaplan-Meier survivorship between the 28-mm head M2a RingLoc MoM THA and the reference group for any reason for revision (87.7% [82.9-92.1] and 83.3% [81.0-85.3], respectively). The adjusted hazard ratio (HR) for any reason for revision for the MoM THA group compared with the reference group was at least equal or better (0.70 [0.48-1.02]). Both groups presented similar survival for revision for aseptic loosening of the cup, osteolysis, liner wear, or metallosis, at 96.2% (92.7-98.0) and 95.4% (93.9-96.5), respectively. In the long-term survival there was no difference between the M2a 28-mm RingLoc MoM THA and 28-mm MoP THA. Further follow-up regimens for M2a 28-mm RingLoc THA patients may be unnecessary, but long-term metal ion and radiological data is needed before any formal suggestions. |
| Author | Matilainen, Markus Haapakoski, Jaason Palomäki, Antton Kettunen, Jukka Vasara, Anna Mäkelä, Keijo T Pamilo, Konsta Puhto, Ari-Pekka Eskelinen, Antti Hemmilä, Matias Manninen, Mikko |
| Author_xml | – sequence: 1 givenname: Antton surname: Palomäki fullname: Palomäki, Antton – sequence: 2 givenname: Matias orcidid: 0000-0003-3727-9036 surname: Hemmilä fullname: Hemmilä, Matias – sequence: 3 givenname: Markus surname: Matilainen fullname: Matilainen, Markus – sequence: 4 givenname: Antti orcidid: 0000-0003-0302-0253 surname: Eskelinen fullname: Eskelinen, Antti – sequence: 5 givenname: Jaason orcidid: 0000-0001-5145-3956 surname: Haapakoski fullname: Haapakoski, Jaason – sequence: 6 givenname: Ari-Pekka orcidid: 0000-0002-5006-4876 surname: Puhto fullname: Puhto, Ari-Pekka – sequence: 7 givenname: Jukka orcidid: 0000-0002-2797-2497 surname: Kettunen fullname: Kettunen, Jukka – sequence: 8 givenname: Konsta orcidid: 0000-0001-5961-4072 surname: Pamilo fullname: Pamilo, Konsta – sequence: 9 givenname: Mikko surname: Manninen fullname: Manninen, Mikko – sequence: 10 givenname: Anna orcidid: 0000-0001-6706-1674 surname: Vasara fullname: Vasara, Anna – sequence: 11 givenname: Keijo T surname: Mäkelä fullname: Mäkelä, Keijo T |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36445034$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1v1DAQjVAR_YA_wAH5yCWLv-IkHJCqikKlBaQKzpbXHm9cOfZiexftb-JPknTb0nLg5NHMm_dmPO-0OgoxQFW9JnhBGcfvSMsbJlq-oJjSRUMb-qw6mZM1Ex09eohbflyd5nyDMet4j19Ux0xw3mDGT6rfXyMyzlpIEDQgF5AbN16FgvI27dxOebSC8gsgINrV44i-UIWuXVgvo0YjFOXrGOrbAKlg_qY20e-hDHsPAVCJc31wG6RSGVKcFHLZv0cJ8taXjGyKIyoDoEsXgssDOn8EQ9ewdrlAelk9t8pneHX3nlU_Lj9-v_hcL799uro4X9aai67UTBkAps20FOuw7VcN7m3bNIo1RGtBKGAihOkJ1a1piDWs5VRRi5nQnSWCnVVXB14T1Y3cJDeqtJdROXmbiGktpzWc9iC57nCvNON2-lFlxQob6FcwaRjDgOiJ68OBa7NdjWA0hJKUf0L6tBLcINdxJ_sWt4z0E8HbO4IUf24hFzm6rMFPN4K4zZJOw4tGEDZD3zzWehC5v_YE6A4AnWLOCazUrqji4iztvCRYzsaS98aSs7HkbKyplf7Tes_-n6Y_gnnUFw |
| CitedBy_id | crossref_primary_10_1007_s11666_024_01801_8 crossref_primary_10_1016_j_arth_2024_10_051 |
| ContentType | Journal Article |
| Copyright | 2022 The Author(s) 2022 |
| Copyright_xml | – notice: 2022 The Author(s) 2022 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.2340/17453674.2022.5252 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals - NZ url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1745-3682 |
| EndPage | 858 |
| ExternalDocumentID | oai_doaj_org_article_4c809ac34f644af6b0de9be12edd3e1c PMC9707319 36445034 10_2340_17453674_2022_5252 |
| Genre | Journal Article |
| GeographicLocations | Finland |
| GeographicLocations_xml | – name: Finland |
| GroupedDBID | --- .55 04C 0YH 23M 2QV 2WC 34G 36B 39C 4.4 5GY 5RE 5VS 6J9 6PF AAFWJ AAWTL AAYXX ABDBF ABNNA ACGFO ACGFS ACUHS ADBBV ADCVX ADOJX ADRBQ AEGXH AENEX AFKVX AFPKN AJWEG ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BMSDO CAG CITATION CS3 DXH E3Z EAP EBC EBD EBS EBX ECF ECT ECV EHN EIHBH EMB EMK EMOBN ENC ENX EPL EPT ESX F5P GROUPED_DOAJ GX1 H13 HYE KQ8 M48 M4Z O9- OK1 OVT P2P Q~Q RDKPK RNS RPM SV3 TFDNU TFW TR2 TUS W2D WQ9 X7M ~1N CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c468t-3adee3cdffe380f9b509f755a351cc612e0166d912c7d51fd3742a2f036c8f163 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000937161900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1745-3674 1745-3682 |
| IngestDate | Fri Oct 03 12:45:04 EDT 2025 Thu Aug 21 18:38:33 EDT 2025 Fri Jul 11 15:34:39 EDT 2025 Mon Jul 21 06:03:25 EDT 2025 Tue Nov 18 22:16:08 EST 2025 Sat Nov 29 06:10:34 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | https://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c468t-3adee3cdffe380f9b509f755a351cc612e0166d912c7d51fd3742a2f036c8f163 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-3727-9036 0000-0001-5145-3956 0000-0002-5006-4876 0000-0002-2797-2497 0000-0001-5961-4072 0000-0003-0302-0253 0000-0001-6706-1674 |
| OpenAccessLink | https://doaj.org/article/4c809ac34f644af6b0de9be12edd3e1c |
| PMID | 36445034 |
| PQID | 2742656139 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4c809ac34f644af6b0de9be12edd3e1c pubmedcentral_primary_oai_pubmedcentral_nih_gov_9707319 proquest_miscellaneous_2742656139 pubmed_primary_36445034 crossref_citationtrail_10_2340_17453674_2022_5252 crossref_primary_10_2340_17453674_2022_5252 |
| PublicationCentury | 2000 |
| PublicationDate | 20221124 |
| PublicationDateYYYYMMDD | 2022-11-24 |
| PublicationDate_xml | – month: 11 year: 2022 text: 20221124 day: 24 |
| PublicationDecade | 2020 |
| PublicationPlace | Sweden |
| PublicationPlace_xml | – name: Sweden |
| PublicationTitle | Acta orthopaedica |
| PublicationTitleAlternate | Acta Orthop |
| PublicationYear | 2022 |
| Publisher | Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation Medical Journals Sweden |
| Publisher_xml | – name: Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation – name: Medical Journals Sweden |
| SSID | ssj0038490 |
| Score | 2.3766413 |
| Snippet | Background and purpose: Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices... Long-term outcome of small head (28 mm) metal-on-metal (MoM) total hip arthroplasty (THA) is available mainly for Metasul devices (Sulzer Medica, Winterthur,... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 854 |
| SubjectTerms | Arthroplasty Arthroplasty, Replacement, Hip - adverse effects Cimetidine Finland - epidemiology Hip Humans Implants Metal-on-Metal Joint Prostheses - adverse effects Metals Osteolysis Polyethylene |
| Title | No difference in implant survival between 28-mm M2a RingLoc metal-on-metal and metal-on-polyethylene total hip arthroplasty: results from the Finnish Arthroplasty Register |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36445034 https://www.proquest.com/docview/2742656139 https://pubmed.ncbi.nlm.nih.gov/PMC9707319 https://doaj.org/article/4c809ac34f644af6b0de9be12edd3e1c |
| Volume | 93 |
| WOSCitedRecordID | wos000937161900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals - NZ customDbUrl: eissn: 1745-3682 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0038490 issn: 1745-3674 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVAWR databaseName: Taylor & Francis Journals customDbUrl: eissn: 1745-3682 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0038490 issn: 1745-3674 databaseCode: TFW dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nq9QwEA_68OBFFL_Wj0cEbxJfm7RN4k3FxYMu8lDYW2mTCVvYTZdtV3h_k_-kM213fSuiF28lSdvJzCTzG5KZYexl7aXS6AeIogaDDkoKos69F7ICXbigKI3VUGxCLxZmubRfrpX6ojthY3rgkXEXmTOJrZzKAlruKhR14sHWkErwXkHqaPdNtD04U-MerExmp1DIXKhCZ2O4jFRZckFt1IS-oZSvc5nLE5M0ZO7_E9z8_dbkNTM0v8vuTPiRvx3pvsduQLzPfixafqh04oA3kTeb7Rp5xrs9bgWoTHy6j8WlEZsN_ywrfolG61Pr-AYQf4s2iuGBV9H_atq26ytAUaJpAt631L9qthy5RtUVEHj3V284Ouz7dd9xilThiCf5vImx6VZE5HEYvwQKNYLdA_Zt_uHr-49iqsIgXFaYXqjKAyjncRLKJMHWCDGCzvNK5alzCJAAUWPhbSqd9nkavEJvu5IBTaMzAeHeQ3YW2wiPGUd4VZsQElM7BIoyM8hMF3xI64piZO2MpQdBlG5KUU6VMtYluiokvPIgvJKEV5LwZuzV8Z3tmKDjr6PfkXyPIym59tCAKldOKlf-S-Vm7MVBO0pcjHTCUkVo911J594FuWQ4lUejthx_pfBjeaKyGdMnenRCy2lPbFZDwm-rcSNO7ZP_QfxTdpu4QeGUMnvGzvrdHp6zW-5733S7c3ZTL835sJZ-AiYxJPo |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=No+difference+in+implant+survival+between+28-mm+M2a+RingLoc+metal-on-metal+and+metal-on-polyethylene+total+hip+arthroplasty%3A+results+from+the+Finnish+Arthroplasty+Register&rft.jtitle=Acta+orthopaedica&rft.au=Palom%C3%A4ki%2C+Antton&rft.au=Hemmil%C3%A4%2C+Matias&rft.au=Matilainen%2C+Markus&rft.au=Eskelinen%2C+Antti&rft.date=2022-11-24&rft.issn=1745-3682&rft.eissn=1745-3682&rft.volume=93&rft.spage=854&rft_id=info:doi/10.2340%2F17453674.2022.5252&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-3674&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-3674&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-3674&client=summon |